BDBM2764 2-(benzo[d]oxazol-2-ylamino)-4',5',7,8-tetrahydro-1H,2'H-spiro[quinazoline-4,3'-thiophen-1,1-dioxide]-5(6H)-one::US9447087, 24

SMILES O=C1CCCC2=C1C1(CCS(=O)(=O)C1)N=C(Nc1nc3ccccc3o1)N2

InChI Key InChIKey=WRFAPXCHZDSSEA-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 2764   

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM2764(US9447087, 24 | 2-(benzo[d]oxazol-2-ylamino)-4',5'...)
Affinity DataIC50: 6.68E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
US Patent